| |
| |
|
| Insider
Information: |
Damelio Frank A |
| Relationship: |
Director |
| City: |
Murray Hill |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
582,165 |
|
|
Indirect Shares
|
38,024 |
|
|
| Direct
Value |
$18,264,903 |
|
|
|
Indirect Value
|
$7,592,412 |
|
|
| Total
Shares |
620,189 |
|
|
| Total
Value |
$25,857,315 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Humana Inc |
HUM |
Director |
2016-09-21 |
0 |
2016-09-21 |
20,634 |
Premium* |
|
|
Pfizer Inc |
PFE |
Executive Vice President |
2022-02-26 |
555,941 |
2019-02-04 |
0 |
Premium* |
|
|
Zoetis Inc. |
ZTS |
Director |
2021-02-13 |
14,808 |
2013-02-06 |
0 |
Premium* |
|
|
Hewlett Packard Enterprise Co |
HPE |
Director |
2024-04-10 |
3,444 |
2024-04-10 |
17,390 |
Premium* |
|
|
Catalent, Inc. |
CTLT |
Director |
2023-10-27 |
7,972 |
2023-08-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
101 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2014-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
64,581 |
680,254 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2014-10-30 |
4 |
OE |
$17.03 |
$1,115,499 |
D/D |
65,502 |
501,494 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• – – |
2012-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
75,251 |
622,656 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2015-02-11 |
4 |
S |
$34.12 |
$2,744,861 |
D/D |
(80,200) |
360,686 |
0 |
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
84,959 |
454,891 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2016-05-03 |
4 |
AS |
$33.65 |
$2,930,208 |
D/D |
(87,079) |
372,994 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• – – |
2011-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
87,407 |
513,836 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2022-02-26 |
4 |
D |
$47.72 |
$4,657,943 |
D/D |
(93,977) |
555,941 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2017-08-31 |
4 |
AS |
$34.00 |
$3,209,906 |
D/D |
(94,409) |
337,389 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
96,183 |
684,360 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• – – |
2012-02-24 |
4 |
D |
$21.18 |
$2,064,012 |
D/D |
(97,451) |
525,205 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2013-05-15 |
4 |
AS |
$29.23 |
$2,932,863 |
D/D |
(100,000) |
485,682 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2016-05-26 |
4 |
OE |
$24.43 |
$2,443,000 |
D/D |
100,000 |
472,994 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2016-05-26 |
4 |
S |
$34.47 |
$3,449,115 |
D/D |
(100,000) |
372,994 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2018-02-24 |
4 |
D |
$35.98 |
$3,954,519 |
D/D |
(109,489) |
401,981 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2022-02-23 |
4 |
D |
$46.87 |
$5,689,134 |
D/D |
(114,219) |
522,758 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-23 |
4 |
D |
$41.91 |
$4,950,566 |
D/D |
(116,646) |
405,930 |
0 |
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2009-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
119,744 |
381,506 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2013-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
120,400 |
796,872 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2021-02-27 |
4 |
D |
$33.49 |
$4,272,636 |
D/D |
(124,253) |
483,188 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2022-02-26 |
4 |
OE |
$25.60 |
$3,255,296 |
D/D |
127,160 |
649,918 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-02-28 |
4 |
D |
$33.42 |
$4,644,327 |
D/D |
(130,834) |
425,250 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2014-01-13 |
4 |
AS |
$30.67 |
$4,062,225 |
D/D |
(131,810) |
356,451 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2021-02-25 |
4 |
D |
$33.82 |
$4,628,810 |
D/D |
(133,928) |
454,656 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-02-26 |
4 |
OE |
$34.59 |
$5,013,060 |
D/D |
144,928 |
482,320 |
0 |
- |
|
101 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
